2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
19
Neoplasms
11
Polycystic Ovary Syndrome
9
Neoplasm Metastasis
4
Multiple Myeloma
4
Melanoma
4
Vomiting
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Leiomyoma
3
Head and Neck Neoplasms
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Solid Tumors
2
Skin Neoplasms
2
Sarcoma
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peripheral Nervous System Diseases
2
Ovarian Neoplasms
2
Obesity
2
Nausea
2
Myofibroma
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, B-Cell
2
Leukemia
2
Insulin Resistance
2
Inflammation
2
Infertility, Female
2
Interventions
Cyclophosphamide
83
Peripheral Blood Stem Cell Transplantation
76
fludarabine phosphate
74
Busulfan
60
Cyclosporine
57
Imatinib Mesylate
50
Mycophenolic Acid
49
Antilymphocyte Serum
48
Tacrolimus
44
Radiotherapy
44
Filgrastim
43
Methotrexate
39
Whole-Body Irradiation
34
Dasatinib
34
Methylprednisolone
30
Cord Blood Stem Cell Transplantation
26
nilotinib
25
Melphalan
24
Cytarabine
23
Interferon-alpha
22
Etoposide
20
sargramostim
19
Flow Cytometry
13
Therapeutics
11
Cyclosporins
11
Sirolimus
10
Polymerase Chain Reaction
10
bosutinib
9
Thiotepa
9
Hydroxyurea
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
Tablets
×
Clear all
NCT01827930
2020-12-31
MIM
Institut Bergonié
Phase 3
Terminated
68 enrolled
13 charts